Atorvastatin Lactone 3-O-Methyl Ether

CAS No :

NA

Molecular Formula:

C34H35FN2O4

Molecular Weight:

554.7

Chemical Name:

5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-methoxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide,Atorvastatin δ-Lactone Methyl Ether

Add to Enquiry Basket
Product Enquiry

Related Products

Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

CAS No: ​1315629-79-8 (KLS-A06002)

Molecular Formula:​ C33H35FN2O7

Molecular Weight: ​556.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity D

CAS No: ​148146-51-4

Molecular Formula:​ C26H22FNO4

Molecular Weight: ​431.46

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity A

CAS No: ​1516864-05-3

Molecular Formula:​ C33H35N2O5 : Na

Molecular Weight: ​539.7 : 23.0

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Di epoxide Calcium Salt

CAS No: ​887470-43-1

Molecular Formula:​ C33H34FN2O7

Molecular Weight: ​589.63

Inv. Status:​


Add to Enquiry Basket

Desfluoro Atorvastatin Acetonide Tert-Butyl Ester

CAS No: ​1105067-91-1

Molecular Formula:​ C40H48N2O5

Molecular Weight: ​556.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity E

CAS No: ​1428118-38-0

Molecular Formula:​ C33H34FN2O5Na

Molecular Weight: ​557.6 : 23.0

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Diamino Impurity

CAS No: ​1116118-82-1

Molecular Formula:​ C50H64FN3O8

Molecular Weight: ​556.6

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity F

CAS No: ​887196-24-9 (acid) ; 1105067-87-5

Molecular Formula:​ C40H47FN3NaO8

Molecular Weight: ​739.8

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Difluoro Impurity

CAS No: ​693793-82-7

Molecular Formula:​ C26H23F2NO3

Molecular Weight: ​435.47

Inv. Status:​


Add to Enquiry Basket

API – Impurities | Specialty Chemicals

Dribbble Pinterest

About

Kemiezen Lifesciences is established with a zeal of support the world with the best chemistry solutions with a group of dedicated scientists having 15 years of experience in the pharmaceutical industry.

Contact Us